Quantitative Systematic Strategies LLC Cogent Biosciences, Inc. Transaction History

Quantitative Systematic Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$5.99 - $9.14 $134,619 - $205,412	-22,474 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$7.82 - $9.3 $197,744 - $235,169	-25,287 Reduced 52.94%	22,474 $182,000
Q1 2021 May 06, 2021	BUY	$7.47 - $12.34 $80,900 - $133,642	10,830 Added 29.32%	47,761 $419,000
Q4 2020 Feb 09, 2021	BUY	$9.04 - $13.01 $333,856 - $480,472	36,931 New	36,931 $415,000

190

104M

157K

439K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $450M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.